A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity
Clinical trial NCT05621616 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05621616
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-28
- Primary completion
- 2026-02-16
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.